🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The primary objective of this study is to evaluate the efficacy of a fixed ...
Status
Completed
Location
University of Alabama at Birmingham
Start Date
2015-11-13
Trial ID
NCT02607930
Treatments Being Tested
The primary objective of this study is to evaluate the safety and tolerabil...
Status
Completed
Location
Mills Clinical Research
Start Date
2017-05-09
Trial ID
NCT03060447
Treatments Being Tested
This study will evaluate the efficacy of switching from emtricitabine/tenof...
Status
Completed
Location
University of Alabama at Birmingham
Start Date
2014-05-06
Trial ID
NCT02121795
Treatments Being Tested
The primary objective of this study is to evaluate the efficacy of switchin...
Status
Completed
Location
Multiple Locations
Start Date
2015-11-11
Trial ID
NCT02603120
Treatments Being Tested
Introduction An increase in cardiovascular disease (CVD) among people livin...
Status
Suspended
Location
Mwananyamala Regional Referral Hospital, Mbagala Rangi Tatu Hospital
Start Date
2020-03-02
Trial ID
NCT05525156
Treatments Being Tested
Dolutegravir (DTG, GSK1349572 is an integrase inhibitor that is currently i...
Status
Completed
Location
GSK Investigational Site
Start Date
2011-12
Trial ID
NCT01498861
Treatments Being Tested
Study ING116529 is a multicenter, randomized, study with an initial 7 day p...
Status
Completed
Location
GSK Investigational Site
Start Date
2012-04-18
Trial ID
NCT01568892
Treatments Being Tested
People infected with HIV often have cognitive dysfunction even if they are ...
Status
Completed
Location
UCLA CARE Center CRS
Start Date
2016-04-21
Trial ID
NCT02519777
Treatments Being Tested
The primary objectives of this study are to evaluate the efficacy, safety, ...
Status
Completed
Location
Spectrum Medical Group
Start Date
2015-06-29
Trial ID
NCT02469246
Treatments Being Tested
GSK1349572 is an integrase inhibitor that is currently being evaluated for ...
Status
Completed
Location
GSK Investigational Site
Start Date
2009-07
Trial ID
NCT00942136
Treatments Being Tested